Інформація опублікована з довідковою метою і не є рекламою, офертою, публічною пропозицією або керівництвом до застосування. Представлена виключно для інформування наших пацієнтів, які перебувають за кордоном. Сайт не здійснює жодної дистанційної торгівлі. Продаж, розповсюдження, доставка та призначення товарів через веб-ресурс не провадяться. Застосування товарів та медичних послуг можливе виключно за призначенням лікаря. Консультації надаються фахівцями клініки у очному форматі або за допомогою дистанційної медичної консультації у рамках чинного законодавства. Прошу звернути Вашу увагу, що у цьому довіднику продаж товарів програмно не передбачено.
Wegovy Medication - An Innovative Solution for Combating Obesity
Wegovy is the latest development by the Danish pharmaceutical company Novo Nordisk A/S. This medication is a reliable aid for adults suffering from excess weight. To date, it has gained significant popularity in Europe and the USA. In Ukraine, it can be purchased at our pharmacy, which offers fast online delivery.
Description and Features of Wegovy
Wegovy is a highly effective weight loss medication. Regular use of Wegovy semaglutide helps reduce body weight by more than 15%, which lowers the risk of developing cardiovascular diseases and type 2 diabetes. The medication also improves anthropometric parameters and quality of life.
Mechanism of Action and Indications
Wegovy Semaglutide acts as a receptor agonist, mimicking the hormone glucagon-like peptide, which controls the feeling of appetite. Wegovy is recommended for patients with a body mass index of 27 kg/m² and above, as well as in cases of obesity (index of 30 kg/m² and above). The medication is also suitable for adults with related conditions such as high cholesterol and type 2 diabetes.
Usage and Contraindications
Wegovy is available in the form of an injectable liquid and is administered subcutaneously once a week. The initial dose is 0.25 mg weekly, with a subsequent monthly increase up to 2.4 mg. The medication has contraindications, including type II endocrine tumors and medullary thyroid carcinoma.
Side Effects and Storage
Some side effects may occur, such as nausea and weakness.
Manufacturer:
Novo Nordisk
Denmark
Temperature Range
2-8 °C
Wegovy is the latest development by the Danish pharmaceutical company Novo Nordisk A/S. This medication is a reliable aid for adults suffering from excess weight. To date, it has gained significant popularity in Europe and the USA. In Ukraine, it can be purchased at our pharmacy, which offers fast online delivery.
Description and Features of Wegovy
Wegovy is a highly effective weight loss medication. Regular use of Wegovy semaglutide helps reduce body weight by more than 15%, which lowers the risk of developing cardiovascular diseases and type 2 diabetes. The medication also improves anthropometric parameters and quality of life.
Mechanism of Action and Indications
Wegovy Semaglutide acts as a receptor agonist, mimicking the hormone glucagon-like peptide, which controls the feeling of appetite. Wegovy is recommended for patients with a body mass index of 27 kg/m² and above, as well as in cases of obesity (index of 30 kg/m² and above). The medication is also suitable for adults with related conditions such as high cholesterol and type 2 diabetes.
Usage and Contraindications
Wegovy is available in the form of an injectable liquid and is administered subcutaneously once a week. The initial dose is 0.25 mg weekly, with a subsequent monthly increase up to 2.4 mg. The medication has contraindications, including type II endocrine tumors and medullary thyroid carcinoma.
Side Effects and Storage
Some side effects may occur, such as nausea and weakness.
Manufacturer:
Novo Nordisk
Denmark
Temperature Range
2-8 °C
